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Edited by Vladimir SkulachevAbstract Recently, we reported that acetylcholine-induced
hypoxia-inducible factor-1a protects cardiomyocytes from
hypoxia; however, the downstream factors reducing hypoxic
stress are unknown. We identiﬁed apoptosis inhibitor (AI) gene
as being diﬀerentially expressed between von Hippel Lindau
(VHL) protein-positive cells with high levels of GRP78 expres-
sion and VHL-negative cells with lower GRP levels, using cDNA
subtraction. AI decreased GRP78 level, suppressed mitochon-
drial function, reduced oxygen consumption and, ultimately, sup-
pressed hypoxia-induced apoptosis. By contrast, knockdown of
the AI gene increased mitochondrial function. Hypoxic cardio-
myocytes and ischemic myocardium showed increased AI mRNA
expression. These ﬁndings suggest that AI is involved in sup-
pressing mitochondrial function, thereby leading to cellular
stress eradication and consequently to protection during hypoxia.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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To develop a novel therapeutic modality against heart fail-
ure, we extensively studied the cardioprotective eﬀects of vagal
nerve stimulation and the mechanisms underlying the anti-
apoptotic actions of acetylcholine (ACh) [1]. Our previous
study showed that induction of hypoxia-inducible factor
(HIF)-1a is further activated by ACh in cardiomyocytes, even
in normoxia. This additive induction of hypoxia-inducible fac-
tor-1a (HIF-1a) rescues cardiomyocytes from prolonged hyp-
oxic stress and suppresses hypoxia-induced cell death [2].
These signiﬁcant results prompted us to investigate which tar-
get genes are regulated by HIF-1a, and to reveal the mecha-
nisms responsible for cardioprotection.
In order to escape from stresses, cells, including cardiomyo-
cytes, possess self-defense systems, including HIF-1a inductionAbbreviations: ACh, acetylcholine; HIF-1a, hypoxia-inducible factor-
1a; UPR, unfolding protein response; ER, endoplasmic reticulum;
VHL, von Hippel Lindau; AI, apoptosis inhibitor; WT, wild-type; DN,
dominant negative type; GFP, green ﬂuorescence protein; siRNA,
small interfering RNA; TFAM, mitochondrial transcription factor A;
RCI, respiratory control index
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doi:10.1016/j.febslet.2007.12.026against hypoxia, the unfolded protein response (UPR) against
accumulated abnormal proteins, and the expression of heat
shock proteins (Hsps) against heat shock [3–5]. Speciﬁcally,
the stress induced by unfolded proteins in the endoplasmic
reticulum (ER), ER stress, has been focused on as one of the
causes of cardiovascular diseases, including cardiac hypertro-
phy and cardiac remodeling [6–8]. The ER plays crucial roles
in protein folding and protein quality sensing, and is essential
for cellular homeostasis. Therefore, ER stress is observed in
situations where protein synthesis is augmented or cell prolif-
eration is potentiated [9–11].
Among a variety of stresses, we have focused on a cardiac
defense mechanism mediated by HIF-1a. The HIF-1a protein
level is regulated by a proteasome system involving von Hippel
Lindau (VHL) protein [12–15]. HIF-1a transcriptionally regu-
lates target genes involved in glycolysis, angiogenesis and
adaptation against hypoxic stress; therefore, HIF-1a induction
might provide cells with fewer stresses, leading to escape from
hypoxic stress. However, it remains unclear which factors are
involved in the anti-stress eﬀects induced by HIF-1a.
Recent studies have demonstrated that HIF-1a is induced
through a non-hypoxic pathway mediated by cytokines, nitric
oxide (NO) and ACh [2,16]. These ﬁndings suggest that a cell
defense system involving HIF-1a is modulated by molecules
other than those involved in hypoxia. In order to elucidate
the precise molecular mechanisms underlying the HIF-1a-reg-
ulated anti-stress eﬀects, we compared VHL-negative and
VHL-positive cells, that is, cells with higher and lower HIF-
1a expression levels, respectively. We found that VHL-nega-
tive cells exhibited lower levels of ER stress. Using these cells,
we subsequently performed a cDNA subtraction assay and
identiﬁed a gene, apoptosis inhibitor (AI) gene, which may
be involved in the anti-stress eﬀects of HIF-1a.2. Materials and methods
2.1. Cell culture
RCC4 cells, referred to as VHL-negative cells, and RCC4 cells with
normal VHL expression, as VHL-positive cells, were generous gifts
from Dr. Patrick H. Maxwell (The Wellcome Trust Center for Human
Genetics, Oxford, UK) [15]. They were cultured in DMEM containing
10% FBS and 1 mg/ml G418. Primary cardiomyocytes isolated from
neonatal rats and H9c2 cells derived from rat ventricular myocytes
were also used. HEK293 (human embryonic kidney) cells, cultured
in DMEM containing 10% FBS, were used for transfections, since
the transfection eﬃciency was better.blished by Elsevier B.V. All rights reserved.
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In order to screen for genes that were more highly expressed in
VHL-negative cells than in VHL-positive cells, a cDNA subtraction as-
say was performed using a SMARTe PCR cDNA Synthesis Kit and a
PCR-Selecte cDNA Subtraction Kit (CLONTECH Laboratories Inc.,
Palo Alto, CA, USA) [17], as previously described [2]. The results of
the subtraction assay were then evaluated by RT-PCR using nested
primers targeting the sequenced genes. After searching the database
using a segment of an interesting gene, the full-length sequences of
interesting genes were obtained from GenBank; and those full-length
genes were subcloned into pcDNA3.1 expression vector with a His
tag sequence, or pIRES-EGFP (Clontech, Mountain View, CA, USA).
2.3. Western blot analysis
Whole cell lysates fromVHL-positive orVHL-negative cellswere frac-
tionated by SDS–PAGE and transferred onto membranes (Millipore
Corp., Bedford, MA, USA). The membranes were incubated with anti-
bodies against GRP78, HIF-1a, VHL (BD Biosciences, San Jose, CA,
USA) or a-tubulin. After reaction with secondary antibodies, the signals
were detected using ECL Plus (Amersham, Buckinghamshire, UK).
2.4. Transfection of HEK293 cells
The AI gene was transfected into HEK293 cells using Eﬀectenee
(QIAGEN, Valencia, CA, USA). In gene knockdown experiments,
siFECTORe (B-Bridge International Inc., Sunnyvale, CA, USA)
was used. In another experiment for transfection, wild-type (WT) or
dominant negative (DN) HIF-1a vector, subcloned into pcDNA3.1
expression vector, was also used [2]. Forty-eight hours after transfec-
tion, the cells were used for further studies.
2.5. Reporter assay for mitochondrial transcription factor A (TFAM)
transcriptional activity
The 5 0-regulatory promoter region of rat TFAM (700 bp) was sub-
cloned into a reporter vector (TOYO B-Net Co. Ltd., Tokyo, Japan)
[18]. The reporter vector was co-transfected with or without the AI
gene expression vector into HEK293 cells. Forty-eight hours later,
the cells were lysed and the luciferase activities were measured and cor-
rected by the levels produced by the SeaPansy luciferase vector (TOYO
B-Net Co. Ltd., Tokyo, Japan).
2.6. RT-PCR
Total RNA was isolated from VHL-negative and VHL-positive cells
and reverse-transcribed to obtain ﬁrst-strand cDNAs, which was
ampliﬁed using speciﬁc primers for the AI gene, as follows: AI (sense),
5 0GAATGCAGAAAAGCTTCATG3 0; AI (antisense), 5 0TAG-
CTAGCTCAGTAGAGTCTTTCCCC3 0. PCR products were frac-
tionated by electrophoresis.
2.7. Assessment of cell number
After performing MTT reduction assays, the cells were treated with
a 0.05% trypsin–0.23 mM EDTA solution. And the cell number of the
suspension was counted.
2.8. MTT activity assay
Measurements of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) reduction activity were performed in cells, which
were transfected with or without the AI gene, containing comparable
cell numbers, using an assay kit (Dojindo, Kumamoto, Japan). The
mitochondrial function of cardiomyocytes was also evaluated using
this assay system [19].
2.9. Caspase-3 activity assay
Caspase-3 activity was measured using an assay kit (MBL, Tokyo,
Japan) [20]. Brieﬂy, cell lysates were mixed with a caspase-3 substrate
and ﬂuorometric measurements were performed. The caspase-3 activ-
ity in hypoxic cells was compared with that in normoxia.
2.10. Flow cytometry analysis
HEK293 cells were cotransfected with green ﬂuorescence protein
(GFP) and AI genes, or transfected with the GFP gene alone, and then
analyzed by ﬂow cytometry to examine whether the AI gene aﬀected
the cell cycle. After suspended cells were ﬁxed in 70% ethanol, they
were treated with RNAase A (1 mg/ml) and mixed with propidiumiodide (20 mg/ml); cells were then analyzed using a FACSCalibur Sys-
tem (Becton Dickinson, Boston, USA). The percentage of each cell cy-
cle phase was compared.
2.11. Immunocytochemistry of transfected cells
Localization of the AI protein was analyzed by immunocytochemis-
try. Transfected HEK293 cells were ﬁxed and treated with 0.1% Triton
X100. After blocking, cells were incubated with an anti-His monoclo-
nal antibody (QIAGEN, Valencia, CA, USA), followed by incubation
with an FITC-conjugated anti-mouse IgG antibody, and ﬁnally ana-
lyzed by ﬂuorescence microscopy.
2.12. Adenoviral infection of the AI gene into rat primary
cardiomyocytes
The full-length humanAI gene was subcloned into the pShuttle vector
possessing CMV promoter according to the protocol. As a negative con-
trol, pShuttle vector containing LacZwas also prepared. After lineariza-
tion, the plasmids were each co-transfected intoEscherichia coli together
with pAd, an adenoviral DNA plasmid (BD Adeno-X Expression Sys-
tem,BDBiosciences, San Jose, CA,USA).Recombinant adenoviral con-
structs were selected, digested with PacI and transfected into HEK293
cells to produce viral particles. Adenoviral infection was performed at
a multiplicity of infection (MOI) of 100. Rat cardiomyocytes were trans-
fected with the adenovirus for 72 h and used for further experiments.
2.13. Analysis of the intracellular calcium response in AI-transfected
cells
pIRES-EGFP expression vector containing the AI gene was trans-
fected into HEK293 cells. After 48 h, these cells were loaded with a
rhod-2 AM ester (5 lM; Molecular Probe, Eugene, OR, USA), and
then stimulated with 100 lMACh, which phosphorylates Akt through
muscarinic receptors. The calcium responses in AI-expressing cells
were evaluated using an imaging system (AQUACOSMOS, Hamama-
tsu Photonics, Hamamatsu, Japan) and analyzing software.
2.14. Measurement of oxygen consumption by cells
At 48 h after transfection, cells were lysed in a lysis buﬀer, and the
mitochondrial fraction was obtained by sequential centrifugation. Pel-
lets were resuspended in a suspension buﬀer, and mitochondrial respi-
ration was initiated by the addition of 30 mM ADP, 1.2 M succinate
and 0.5 M PBS. The mixture was applied to a Biological Oxygen Mon-
itor (YSI Japan Ltd., Tokyo, Japan) and the respiratory control index
(RCI) was evaluated as the ratio of state 3 to state 4 respiration.
2.15. Small interfering RNA (siRNA) for AI
To silence the eﬀect of AI gene expression in HEK293 cells, siRNAs
were used. The best sequence of siRNA duplex was selected, and an
siRNA duplex of 21-nucleotides was synthesized (TAKARA BIO
Inc., Otsu, Japan). The sense strand of the siRNA for the AI gene
(AI siRNA) was GAACAAUGCCCUAUUAAGUTT. Non-speciﬁc
siRNA was also used as a negative control for comparison (CCG-
UUUACAACGAUAGAAUTT, unrelated siRNA). Transfection
was carried out using siFECTOR (B-Bridge International Inc., Sunny-
vale, CA, USA) with 50 pmol/dish siRNA, which was added to 1.5 ll
of siFECTOR according to the manufacturers protocol.
2.16. Statistical analysis
The data are presented as means ± S.E. Mean values were compared
between the two groups using an unpaired Students t-test. Diﬀerences
among data from the in vitro studies were assessed by ANOVA for
multiple comparisons of results. Diﬀerences were considered signiﬁcant
at P < 0.05.3. Results
3.1. VHL-negative cells express more HIF-1a but less GRP78
than VHL-positive cells under normoxia with a decrease in
mitochondrial function
As shown in Fig. 1, the HIF-1a protein level was higher in

































Fig. 1. The protein level of HIF-1a is greatly increased in VHL-
negative cells compared with VHL-positive cells, even under normoxia.
VHL-positive cells express the VHL protein, whereas VHL-negative
cells do not. By contrast, VHL-negative cells express more HIF-1a
protein, even under normoxia, than VHL-positive cells (n = 4).

























































Fig. 2. VHL-negative cells show lower expression of GRP78 protein
with reduced mitochondrial function. (A) Both VHL-positive cells and
VHL-negative cells proliferate well without cell death, as evaluated by
the absence of ﬂoating cells. When the numbers of both cell types are
comparable, evaluated by counting cells, no morphological diﬀerences
are observed. (B) VHL-negative cells show lower GRP78 expression
than VHL-positive cells despite the comparable cell numbers, as
indicated by the a-tubulin expression levels (n = 4). (C) Compatible
with decreased GRP78 expression, VHL-negative cells also show
signiﬁcantly lower MTT reduction activity (74.6 ± 5.3%) than VHL-
positive cells (100.0 ± 3.7%; n = 6, P < 0.01), despite the comparable
cell numbers.
334 Y. Kakinuma et al. / FEBS Letters 582 (2008) 332–340VHL protein level was decreased in the former cells, indicating
that the HIF-1a protein expression level is increased in VHL-
negative cells, even under normoxia.
As shown in Fig. 2A, neither of the cell types showed any
cell death, regardless of the VHL expression level, as evaluated
by the absence of ﬂoating cells. Both cell types comparably
reached 100% conﬂuence. To investigate the other characteris-
tic diﬀerences between them, the expression levels of GRP78,
an ER stress marker, were examined. VHL-negative cells
showed lower GRP78 expression levels than VHL-positive
cells, indicating that the former cells are subjected to less ER
stress (Fig. 2B). Furthermore, MTT reduction activity was
lower in VHL-negative cells (74.6 ± 5.3%) than VHL-positive
cells (100.0 ± 3.7%; n = 6, P < 0.01), despite the comparable
cell numbers (Fig. 2C). This result indicates that the mitochon-
drial function in VHL-negative cells is relatively decreased,
because MTT reduction activity depends on mitochondrial
respiratory chain function.
3.2. cDNA subtraction to identify genes responsible for the lower
expression of GRP78
VHL-negative cells, with a high HIF-1a level under nor-
moxia, showed a decreased GRP78 expression in response to
stress. Therefore, we hypothesized that VHL-negative cells
show less stress than VHL-positive cells, and that some HIF-
1a-regulated genes, which modulate the stress level, could be
identiﬁed by screening via cDNA subtraction between two cell
types. Thereafter, we obtained one gene, which had already
been reported, with the GenBank accession number
(BT008120) and tentatively named apoptosis inhibitor (AI) 5
gene. As depicted in Fig. 3A, the AI mRNA level was
increased in VHL-negative cells compared with VHL-positive
cells. The AI mRNA expression levels were increased by
hypoxia (1% oxygen) in both HEK293 and H9c2 cells
(Fig. 3B), suggesting that AI expression is induced by hypoxia.
Analysis of the tentative 5 0-promoter region of the AI gene in
the EMBL database revealed one hypoxia-responsive element
(HRE), a DNA-binding site for HIF-1a, in that region
(AY265937). This ﬁnding may support our results.3.3. HIF-1a increases AI mRNA levels and negatively aﬀects
GRP78 expression
To conﬁrm that HIF-1a directly aﬀects AI gene expression
and, furthermore, GRP78 expression, the eﬀects of wild-type
(WT) HIF-1a on the expression of AI gene were compared
with those of dominant negative (DN) HIF-1a. AI mRNA
expression was decreased by DN HIF-1a, compared with
WT HIF-1a (69.3 ± 0.8% vs. 175.3 ± 11.8%, n = 6, P < 0.01)
(Fig. 3C). By contrast, DN HIF-1a adversely increased the
GRP78 expression level, compared with WT HIF-1a
(190.9 ± 2.7% vs. 114.4 ± 2.7%; n = 3, P < 0.05). The diﬀerence
in the eﬀects of WT and DN HIF-1a on AI mRNA or GRP78
expression was more evident than between those of control
and WT HIF-1a. These ﬁndings suggest that HIF-1a positively










































































Fig. 3. The expression of the AI gene, which is localized in the nucleus, is increased under hypoxia and involved in the reduction of GRP78
expression through HIF-1a. (A) Even under normoxia, AI mRNA gene expression is increased in VHL-negative cells compared with VHL-positive
cells, as evaluated by RT-PCR (n = 5). (B) AI mRNA expression is increased by hypoxia (1% oxygen) in HEK293 cells as well as H9c2 cells (n = 5).
(C) The wild-type form (WT) of HIF-1a slightly increases AI gene expression; however, the dominant negative form (DN) adversely decreases AI
gene expression, as evaluated by RT-PCR (n = 6, P < 0.01). (D) Compared with WT HIF-1a, GRP78 expression was up-regulated by DN HIF-1a
(n = 3, P < 0.05). (E) AI suppresses the increase in GRP78 expression in HEK293 cells induced by 5 lg/ml tunicamycin; adversely non-transfected
control cells, GFP-transfected cells and empty vector-transfected cells all responded to tunicamycin with elevated GRP78 expression (n = 5). (F)
Labeling with an anti-His tag antibody reveals that the His-tagged AI protein is localized in the nucleus, and not in the cytoplasm.
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expression (Fig. 3D).
3.4. Nuclear AI is involved in the reduced GRP78 expression
To investigate the function of the AI gene, the GRP78 re-
sponse was assessed in the presence of tunicamycin, an ER
stressor. In the presence of tunicamycin, the GRP78 expression
levels were increased in non-transfected control cells, GFP-
transfected cells and empty expression vector-transfected cells.
However, compared with these cells showing increased GRP78
levels, AI-transfected cells exhibited remarkably decreased
GRP78 expression (Fig. 3E). Using an anti-His tag antibody,
AI was detected in the nucleus (Fig. 3F). However, the propor-
tions of cells at each cell cycle phase were comparable between
the AI-transfected cells and non-transfected cells (55.0% and
58.6% in G1 phase, 28.8% and 25.9% in S phase, and 16.3%Fig. 4. The AI gene regulates mitochondrial function by modifying the trans
leading to a decrease in oxygen consumption, and inhibition of hypoxia-induc
decreased (to 43.0 ± 2.5%) compared with that in GFP-transfected cells (10
Reporter assays reveal that AI suppresses the transcriptional activity of TF
(378 ± 15 to 267 ± 10 RLU in basic vector, 739 ± 55 to 397 ± 19 RLU in SV
TFAM). (C) The calcium response is reduced by AI. Intracellular calcium
application of 100 lM ACh. However, in AI-transfected HEK293 cells the r
calcium response traces are shown. (D) Transient transfection of the AI gene
that in GFP-transfected cells, as evaluated by the RCI. Furthermore, rat pr
oxygen consumption (n = 5, P < 0.05 vs. GFP or LacZ). (E) Caspase-3 acti
elevation of caspase-3 activity (n = 5, P < 0.01 vs. control). (F) Knockdown
HEK293 cells under ordinary culture conditions, compared with that of non
p < 0.01 vs. control or unrelated siRNA). (G) Myocardial ischemia for 3 h in
non-ischemic heart, as evaluated by RT-PCR (n = 4).and 15.4% in G2 + M, respectively) (data not shown), suggest-
ing that AI does not aﬀect the cell cycle.
3.5. AI modiﬁes mitochondrial function through downregulation
of TFAM
Despite the presence of comparable cell numbers, as shown
in Fig. 4A, MTT reduction activity was decreased in AI-trans-
fected cells (to 43.0 ± 2.5%) compared with GFP-transfected
cells (101 ± 3.1%; n = 8, P < 0.01), indicating that AI inhibits
mitochondrial function, as occurs in VHL-negative cells
(Fig. 2C), since the MTT reduction activity reﬂects complex
II activity in mitochondria. To investigate the mechanism by
which mitochondrial function is aﬀected by AI, reporter assays
were carried out using a 5 0-ﬂanking regulatory region of the
human TFAM gene. TFAM is an essential transcription factor
encoded by nuclear DNA, which regulates the transcription ofcriptional activation of mitochondrial transcription factor A (TFAM),
ed apoptosis. (A) The MTT reduction activity in AI-transfected cells is
1.3 ± 3.1%; n = 8, P < 0.01), despite the comparable cell numbers. (B)
AM in two diﬀerent luciferase vectors, compared with TFAM alone
promoter vector, n = 8 in each reporter assay experiment, P < 0.01 vs.
accumulation in HEK293 cells is increased in response to exogenous
esponse is suppressed (n = 20, P < 0.05 vs. GFP). Four representative
into HEK293 cells decreases their oxygen consumption compared with
imary cardiomyocytes infected with AI adenovirus also show reduced
vity in HEK293 cells is increased by hypoxia, and AI suppresses this
of the AI gene signiﬁcantly increases the MTT reduction activity in
-transfected control cells or unrelated siRNA-transfected cells (n = 10,
creased the level of AI mRNA expression in the heart, compared with
Fig. 4 (continued)
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ter vector in the presence of the TFAM ﬂanking region
(TFAM) was 378 ± 15 RLU or 739 ± 55 RLU compared with
the basic vector or SV promoter vector alone, respectively
(Fig. 4B). By contrast, AI decreased the luciferase activity
(TFAM + AI) to 267 ± 10 RLU or 397 ± 019 RLU, respec-
tively, suggesting that AI interferes with TFAM transcrip-
tional activation (n = 8, P < 0.01 vs. TFAM), and inhibits
mitochondrial function.
3.6. AI attenuates calcium response following stimulation
The facts that AI reduces GRP78 expression, TFAM tran-
scription and mitochondrial function prompted us to speculate
that AI suppresses various cellular responses, including the cal-
cium response. Therefore, we investigated the eﬀect of AI on
the calcium response. It had already been conﬁrmed that
ACh phosphorylates Akt and modulates intracellular calciumlevels in HEK293 cells (data not shown). Intracellular calcium
levels were elevated in GFP-transfected cells stimulated by
ACh (100 lM) (upper panel in Fig. 4C). This elevation was
comparable with the calcium responses seen in non-transfected
HEK293 cells (data not shown). However, as shown in the
lower panel, the calcium responses in AI-transfected cells were
remarkably attenuated, suggesting that AI aﬀects the calcium
response (n = 20, P < 0.05 vs. GFP).
3.7. AI gene decreases oxygen consumption in cardiomyocytes
Oxygen consumption was evaluated using the RCI
(Fig. 4D). In AI-transfected HEK293 cells, the RCI was de-
creased (to 1.3 ± 0.1), compared with that in GFP-transfected
cells (2.0 ± 0.1; n = 5, P < 0.05). Likewise, adenoviral infection
of AI into rat primary cardiomyocytes caused a decrease in
RCI (to 1.5 ± 0.1), compared with that in LacZ-transfected
cells (2.0 ± 0.1; n = 5, p < 0.05). These results indicate that
Fig. 4 (continued)
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energy metabolism.
3.8. AI decreases the hypoxia-induced elevation of caspase-3
In the absence of the AI gene, hypoxia (1% oxygen)
increased caspase-3 activity (to 128.0 ± 3.0%). By contrast,
hypoxia did not increase caspase-3 activity in AI-transfected
HEK293 cells (89.5 ± 1.4%; n = 5, P < 0.01) (Fig. 4E), suggest-
ing that AI inhibits the apoptosis induced by hypoxia. AI was
identiﬁed to suppress mitochondrial function, therefore, itcould be speculated that AI is induced by an adaptation to
hypoxia. Inadequate induction level of AI cannot eﬃciently
prevent hypoxia-induced apoptosis; however, greater levels
of AI induction could lead to cellular protection.
3.9. Knockdown of AI using siRNA increases MTT reaction
activity even with comparable cell numbers
To clarify the signiﬁcance of AI, AI siRNA or unrelated siR-
NA was transfected into HEK293 cells. Initially, the eﬃciency
of siRNA to knockdown AI expression was veriﬁed (Fig. 4F).
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by the AI siRNA. Compared with the MTT reduction activi-
ties in non-transfected cells (control, 100 ± 6.3%) or unrelated
siRNA-transfected cells (unrelated siRNA, 98.7 ± 5.1%), the
MTT activities of AI siRNA-transfected cells were signiﬁ-
cantly higher, even with adjustment for cell numbers (AI
siRNA, 150.0 ± 6.0%; n = 10, p < 0.01 vs. control and unre-
lated siRNA). Taken together with the results from the AI
gene introduction study, this ﬁnding suggests that AI plays a
pivotal role in regulating mitochondrial function.
3.10. Acute myocardial ischemia increases AI mRNA
Ischemia of the heart, induced by left coronary ligation for
3 h, resulted in an increase in AI mRNA expression
(Fig. 4G), consistent with an earlier ﬁnding in H9c2 cells,
which showed increased AI mRNA expression in response to
hypoxic stress (Fig. 3B). This in vivo result suggests that AI
induction by ischemia may be due to adaptation of the heart.4. Discussion
The present study revealed that AI exerts anti-stress eﬀects
by suppressing mitochondrial function, thereby reducing oxy-
gen consumption and inhibiting hypoxia-induced apoptosis.
These eﬀects are achieved via transcriptional repression of
mitochondrial transcription factor A (TFAM). This study,
therefore, shows that AI plays a crucial role in suppressing
mitochondria during hypoxia, leading to the salvaging of cells.
These results suggest a potential advantage of a non-hypoxic
induction pathway of HIF-1a in a clinical setting. We have re-
cently revealed that ACh exerts a cardioprotective action
through the PI3K/Akt/HIF-1a/VEGF signaling pathway,
and that it inhibits the collapse of mitochondria membrane po-
tential [2]. Therefore, the possibility is raised that the beneﬁcial
eﬀects of ACh might be attributed to modulation of cardiac
mitochondria. However, there are few adequate studies regard-
ing the linkage between ACh and mitochondrial function in
cardiomyocytes. Therefore, we have studied which factors
might link HIF-1a to mitochondrial function and then found
a cue from AI gene.
TFAM plays key roles in mitochondrial DNA maintenance
and mitochondrial biogenesis, since complete inactivation of
TFAM causes cardiomyopathy [21,22]. Therefore, TFAM is
deﬁnitely essential for the homeostasis of energy metabolism
in cells. In the present study, however, AI partially decreased
the TFAM promoter activity and suppressed oxygen con-
sumption. It was therefore revealed that the principal function
of AI is to decrease energy metabolism, and that AI plays a
role in protecting cells against hypoxia. Since AI is screened
from cells with higher expression levels of HIF-1a, these results
are compatible, and suggest that AI is one of the targets of
HIF-1a responsible for cell protection against hypoxic condi-
tions.
The AI gene has already been reported under GenBank
accession number BT008120 as an apoptosis inhibitor (AI).
One study reported another related gene, designated the
AAC-11 gene, which shows partial amino acid sequence iden-
tity to the AI gene [23]. AAC-11 gene-transfected cells are
resistant to apoptosis [23,24]; just as AI-transfected cells are
resistant to hypoxia-induced apoptosis. It was demonstrated
that increased AAC-11 mRNA expression is correlated witha poor prognosis for patient with non-small cell carcinoma
[24] and cervical carcinoma [25]. Unlike AAC-11, however,
the functions of BT008120, AI, have remained unknown.
Therefore, our present study reveals a novel function of AI
in terms of the modiﬁcation of mitochondrial function.
Based on the facts that VHL-negative cells with higher HIF-
1a expression levels showed lower MTT reduction activity
than VHL-positive cells, it is suggested that VHL-negative cells
utilize less mitochondrial function, because the MTT reduction
activity represented by complex II activity is reduced. It is fur-
ther suggested that increased HIF-1a expression is adversely
related to decreased mitochondrial function. Compatible with
this, the levels of AI mRNA were increased by hypoxia and
ischemia, and AI gene expression was increased by HIF-1a.
Cardiomyocytes, which are rich in mitochondria, eﬃciently
produce adequate ATP through the mitochondrial respiratory
chains, but simultaneously produce endogenous reactive oxy-
gen species (ROS). It was also established that mitochondria
play crucial roles in executing apoptosis [26,27]; therefore, b-
blockers are widely used in patients with heart failure to
achieve a better outcome [28–32] through the reduction of car-
diac work, as AI suppresses mitochondrial energy metabolism
via a decrease in oxygen consumption. Consequently, it is sug-
gested that AI suppresses energy metabolism, resulting in the
circumvention of apoptotic stresses.
In agreement with this, AI also decreased the level of GRP78
expression, suggesting that AI reduces cellular stress, decreases
caspase-3 activity induced by hypoxia and attenuates the cal-
cium response. The UPR is activated by stresses and up-regu-
lates protective ER-related proteins, including GRP78. Recent
studies have revealed that hypoxia causes ER stress in cardio-
myocytes with elevated GRP78 levels [33,34]. According to an
elegant study by Terai et al. [34], activation of a cell-protective
kinase (AMPK) inhibits apoptosis without GRP78 induction.
A crucial point in our present study is that AI also exerts cell-
protective eﬀects upstream of GRP78, and primarily makes
cells more resistant to stress by suppressing energy metabo-
lism. It is therefore speculated that a reduction of energy
metabolism by AI is associated with the diminution of oxida-
tive stresses, lower proliferation and decreased protein synthe-
sis, and that these mechanisms could decrease ER stress [35].
Consequently, this study reveals a missing link between AI,
HIF-1a, mitochondria and stresses.
Although AI decreased MTT reduction activity in nor-
moxia, leading to decreased mitochondrial function, MTT
reduction activity was surprisingly up-regulated by knock-
down of AI, indicating that mitochondrial function is
adversely activated by AI siRNA. Taken together, these ﬁnd-
ings suggest that AI plays a critical role in negatively modulat-
ing mitochondrial function.
In conclusion, the present study has identiﬁed the AI gene,
which is regulated by HIF-1a, as a candidate gene that may
be involved in the inhibition of energy metabolism and apop-
tosis under hypoxic conditions. These eﬀects of AI could con-
tribute to cellular protection.
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